This expert committee of HF experts are going to look at the C-Puse patients and say no way is this random? It should be available to the control arm. Back to the FDA.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks
CUF CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch
